 

Term

Description

 

Net QIB Portion

The QIB Portion less the number of Equity Shares allocated to the Anchor Investors

 

Nomura

Nomura Financial Advisory and Securities (India) Private Limited

 

Non-Institutional Bidders

All Bidders that are not QUBs or Retail Individual Bidders or Eligible Employees and who have Bid for
Equity Shares for an amount of more than %200,000 (but not including NRIs other than Eligible NRIs)

 

Non-Institutional Portion

Portion of the Offer being not less than 15% of the Net Offer consisting of 2,625,556" Equity Shares
which were made available for allocation on a proportionate basis to Non-Institutional Bidders, subject
to valid Bids being received at or above the Offer Price

“Subject to finalisation of the Basis of Allotment

 

Non-Resident

Person resident outside India, as defined under FEMA

 

 

Offer The initial public offer of Equity Shares comprising of the Fresh Issue and the Offer for Sale. The Offer
comprises the Net Offer and Employee Reservation Portion.
Offer Agreement The agreement dated August 16, 2021 entered into amongst our Company and the Investor Selling

Shareholder and the BRLMs, pursuant to which certain arrangements have been agreed to in relation to
the Offer, as amended by way of an amendment agreement dated November 28, 2021

 

Offer for Sale

The offer for sale of 10,028,831" Equity Shares aggregating to 7,982.95 million (the “Offer for Sale”),
comprising of 7,826,626 Equity Shares aggregating to %6,230 million by PI Opportunities Fund — I
(“Investor Selling Shareholder”), 1,344,221 Equity Shares aggregating to 21,070.00 million by S. S.
Pharma LLC, 402,010 Equity Shares aggregating to 2320.00 million by Shore Pharma LLC, 125,628
Equity Shares aggregating to 2100.00 million by Natco Pharma Limited, 125,628 Equity Shares
aggregating to 2100.00 million by Time Cap Pharma Labs Private Limited, 89,547 Equity Shares
aggregating to 271.28 million by A. Raghava Reddy, 53,115 Equity Shares aggregating to 242.28
million by K Prakurthi, 27,135 Equity Shares aggregating to 221.60 million by Navdeep Patyal, 18,467
Equity Shares aggregating to 214.70 million by Sangeeta Raju, 14,974 Equity Shares aggregating to
211.92 million by R. Venkat Reddy, 276 Equity Shares aggregating to % 0.22 million by TK Kurien, 251
Equity Shares aggregating to 20.20 million by Nithya Venkataramani, 251 Equity Shares aggregating to
20.20 million by Atul Gupta, 251 Equity Shares aggregating to 20.20 million by Manoj Jaiswal, 251
Equity Shares aggregating to 0.20 million by Rahul Garg, 100 Equity Shares aggregating to 20.08
million by Kollengode Ramanathan Lakshminarayana and 100 Equity Shares aggregating to 20.08
million by Bijou Kurien

 

“Subject to finalisation of the Basis of Allotment

 

Offer Price

796 per Equity Share, being the final price at which Equity Shares will be Allotted to successful ASBA
Bidders (except for the Anchor Investors) in terms of the Red Herring Prospectus and this Prospectus.
Equity Shares will be Allotted to Anchor Investors at the Anchor Investor Offer Price which was decided
by our Company and the Investor Selling Shareholder, in consultation with the BRLMs in terms of the
Red Herring Prospectus and this Prospectus.

The Offer Price was decided by our Company and the Investor Selling Shareholder, in consultation with
the BRLMs on the Pricing Date in accordance with the Book Building Process and the Red Herring
Prospectus

A discount of 9.80% on the Offer Price (equivalent of 278 per Equity Share) may be offered to Eligible
Employees bidding in the Employee Reservation Portion. This Employee Discount was decided by our
Company and the Investor Selling Shareholder, in consultation with the Book Running Lead Managers

 

Offer Proceeds

The proceeds of the Fresh Issue which shall be available to our Company and the proceeds of the Offer
for Sale which shall be available to the Selling Shareholders. For further information about use of the
Offer Proceeds, see “Objects of the Offer” on page 104

 

Offered Shares

10,028,831 Equity Shares aggregating to 7,982.95" million comprising of 7,826,626 Equity Shares
aggregating to 26,230 million by PI Opportunities Fund — 1, 1,344,221 Equity Shares aggregating to
21,070.00 million by S. S. Pharma LLC, 402,010 Equity Shares aggregating to 2320.00. million by
Shore Pharma LLC, 125,628 Equity Shares aggregating to 2100.00 million by Natco Pharma Limited,
125,628 Equity Shares aggregating to 2100.00 million by Time Cap Pharma Labs Private Limited,
89,547 Equity Shares aggregating to 271.28 million by A. Raghava Reddy, 53,115 Equity Shares
aggregating to 242.28 million by K Prakurthi, 27,135 Equity Shares aggregating to 221.60 million by
Navdeep Patyal, 18,467 Equity Shares aggregating to 214.70 million by Sangeeta Raju, 14,974 Equity
Shares aggregating to 211.92 million by R. Venkat Reddy, 276 Equity Shares aggregating to % 0.22
million by TK Kurien, 251 Equity Shares aggregating to 20.20 million by Nithya Venkataramani, 251
Equity Shares aggregating to 20.20 million by Atul Gupta, 251 Equity Shares aggregating to 20.20
million by Manoj Jaiswal, 251 Equity Shares aggregating to 20.20 million by Rahul Garg, 100 Equity
Shares aggregating to 20.08 million by Kollengode Ramanathan Lakshminarayana and 100 Equity
Shares aggregating to 20.08 million by Bijou Kurien

Subject to finalisation of the Basis of Allotment

 

 

Price Band

 

Price band of a minimum price of 2780 per Equity Share (ie., the Floor Price) and the maximum price
of 2796 per Equity Share (i.e., the Cap Price) including any revisions thereof.

‘The Price Band. the Employee Discount and the minimum Bid Lot for the Offer will be decided by our
Company and the Investor Selling Shareholder, in consultation with the BRLMs, and will be advertised,
at least two Working Days prior to the Bid/ Offer Opening Date, in all editions of Financial Express, an
English national daily newspaper and all editions of Jansatta, a Hindi national daily newspaper and the
Hyderabad edition of Suryaa, a Telugu daily newspaper, (Telugu being the regional language of

 

ye

 
